Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by kurosagii1on Apr 25, 2016 7:22am
93 Views
Post# 24805211

Exclusive: Perrigo to name Hendrickson CEO as Papa joins Val

Exclusive: Perrigo to name Hendrickson CEO as Papa joins Valhttps://www.reuters.com/article/us-perrigo-ceo-valeant-idUSKCN0XM15G?type=companyNews

Drugmaker Perrigo Co Plc (PRGO.N) has decided to let Chief Executive Officer Joseph Papa join Valeant Pharmaceuticals International Inc (VRX.TO) as CEO and replace him with President John Hendrickson, according to people familiar with the matter.

Perrigo's board agreed on Monday to waive a non-compete restriction in Papa's employment contract that would have stopped him from joining Valeant, the people said, requesting anonymity because there has not yet been any official announcement.

Hendrickson, who has been with Perrigo for 27 years and previously led several of its operations, including its U.S. consumer healthcare business, will become CEO effective immediately, the people added.

Perrigo's board also decided to separate the roles of CEO and chairman, and it named one of its directors, Laurie Brlas, as its new chairman, the people said.

Perrigo declined to comment, while Valeant did not immediately respond to a request for comment.

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse